Leitlinienprogramm OnkologieBreast Cancer

13. Tabellenverzeichnis – Breast Cancer

Version 4.4 · May 2021 · AWMF 032/045OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Beteiligte Fachgesellschaften und Organisationen

Arbeitsgruppen

Abkürzungen

B-classification for punch and vacuum biopsies

Indication algorithm for radiation therapy after neoadjuvant therapy

Common Terminology Critera for Adverse Events (CTCAE, Version 4.03)

Emetogenes Potenzial der beim Mammakarzinom verwendeten einzelnen Zytostatika, aktualisiert 5/2012

Strahlentherapiespezifische Faktoren des emetogenen Risikos

Zusammenfassung der antiemetischen Prophylaxe

Anemia workup

Stages and diagnostic workup of iron deficiency

Recommendations for RBC transfusion in acuute anemia as pre cross-sectional guidelines (BÄK) for therapy with blood components 2014

Follow-up examinations in breast cancer

Follow-up examinations for breast cancer – Breast diagnostics after BCT or mastectomy

Use of complementary methods, observed side effects, potential interactions

Risikofaktoren für Männer, an einem Mammakarzinom zu erkranken

Nuklear Grading of DCIS

WHO grading of DCIS

WHO classification of invasive breast carcinomas

Criteria for grading breast cancer

Assignment of scores for mitotic count as a function of field diameter

Nottingham Prognostic Index

Immunohistochemistry scores for hormone receptor assessment

CPS+EG-Score

Side effects and long-term effects of treatment in women and men with breast cancer: Aligned to ASCO Guideline Survivorship (guideline adaptation)